JPH0119393B2 - - Google Patents
Info
- Publication number
- JPH0119393B2 JPH0119393B2 JP58122444A JP12244483A JPH0119393B2 JP H0119393 B2 JPH0119393 B2 JP H0119393B2 JP 58122444 A JP58122444 A JP 58122444A JP 12244483 A JP12244483 A JP 12244483A JP H0119393 B2 JPH0119393 B2 JP H0119393B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- group
- general formula
- compound
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 38
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 14
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 11
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 10
- 239000003960 organic solvent Substances 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 5
- 238000007363 ring formation reaction Methods 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 4
- 238000003402 intramolecular cyclocondensation reaction Methods 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- 229920000137 polyphosphoric acid Polymers 0.000 claims description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 7
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims 1
- ZQXCQTAELHSNAT-UHFFFAOYSA-N 1-chloro-3-nitro-5-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(Cl)=CC(C(F)(F)F)=C1 ZQXCQTAELHSNAT-UHFFFAOYSA-N 0.000 claims 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims 1
- 238000010306 acid treatment Methods 0.000 claims 1
- 229910052796 boron Inorganic materials 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- 239000000203 mixture Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000012670 alkaline solution Substances 0.000 description 5
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 5
- NKLCHDQGUHMCGL-UHFFFAOYSA-N cyclohexylidenemethanone Chemical group O=C=C1CCCCC1 NKLCHDQGUHMCGL-UHFFFAOYSA-N 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- -1 boron trifluoride ether complexes Chemical class 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GTRDOUXISKJZGL-UHFFFAOYSA-N 1,2,3,6,7,11b-hexahydropyrazino[2,1-a]isoquinolin-4-one Chemical compound C1=CC=C2C3CNCC(=O)N3CCC2=C1 GTRDOUXISKJZGL-UHFFFAOYSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- NMPVEAUIHMEAQP-UHFFFAOYSA-N 2-Bromoacetaldehyde Chemical compound BrCC=O NMPVEAUIHMEAQP-UHFFFAOYSA-N 0.000 description 2
- UAAQABVSUSSPBW-UHFFFAOYSA-N 9,10-dimethoxy-1,2,3,6,7,11b-hexahydropyrazino[2,1-a]isoquinolin-4-one Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN2C1CNCC2=O UAAQABVSUSSPBW-UHFFFAOYSA-N 0.000 description 2
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 150000001241 acetals Chemical class 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- WZZJAYPARCLIPG-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinolin-1-ylmethanamine Chemical compound C1=CC=C2C(CN)NCCC2=C1 WZZJAYPARCLIPG-UHFFFAOYSA-N 0.000 description 1
- QKWWDTYDYOFRJL-UHFFFAOYSA-N 2,2-dimethoxyethanamine Chemical compound COC(CN)OC QKWWDTYDYOFRJL-UHFFFAOYSA-N 0.000 description 1
- FSVJFNAIGNNGKK-UHFFFAOYSA-N 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1CCCCC1 FSVJFNAIGNNGKK-UHFFFAOYSA-N 0.000 description 1
- LYIIBVSRGJSHAV-UHFFFAOYSA-N 2-aminoacetaldehyde Chemical class NCC=O LYIIBVSRGJSHAV-UHFFFAOYSA-N 0.000 description 1
- XEYCCEDRIDKXEV-UHFFFAOYSA-N 2-benzoyl-3,6,7,11b-tetrahydro-1h-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1=CC=CC=C1 XEYCCEDRIDKXEV-UHFFFAOYSA-N 0.000 description 1
- LNWWGHNQLOXRTF-UHFFFAOYSA-N 2-chloro-n-(2-phenylethyl)acetamide Chemical compound ClCC(=O)NCCC1=CC=CC=C1 LNWWGHNQLOXRTF-UHFFFAOYSA-N 0.000 description 1
- WWBJEBQJHYKQHM-UHFFFAOYSA-N 2-chloro-n-[2-(3,4-dimethoxyphenyl)ethyl]acetamide Chemical compound COC1=CC=C(CCNC(=O)CCl)C=C1OC WWBJEBQJHYKQHM-UHFFFAOYSA-N 0.000 description 1
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 1
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000242678 Schistosoma Species 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Substances FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- WOHOHPONCSKXSQ-UHFFFAOYSA-N n-ethyl-2-phenylethanamine Chemical compound CCNCCC1=CC=CC=C1 WOHOHPONCSKXSQ-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229940117803 phenethylamine Drugs 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
本発明は(±)―4―オキソ―1,2,3,
6,7,11b―ヘキサヒドロ―4H―ピラジノ
〔2,1―a〕イソキノリン誘導体についての新
しい改良された製造方法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention provides (±)-4-oxo-1,2,3,
This invention relates to a new and improved production method for 6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinoline derivatives.
本発明の化合物は次の一般式で表わされる。 The compound of the present invention is represented by the following general formula.
ここでR1は水素、低級アルキル基又はR4COで
あり、R2およびR3はそれぞれ別個に水素、低級
アルキル基及びアルコキシ基であり、R4は水素、
低級アルキル基、シクロアルキル基又はアリル基
である。ここで使用される「低級アルキル基」と
は直鎖及び分枝したC1〜C6アルキル基を意味し、
「アルコキシ基」は直鎖及び分枝したC1〜C6アル
コキシ基を意味する。「シクロアルキル」とは環
構成炭素数が3〜6個のシクロアルキル基(例、
シクロプロピル、シクロブチル、シクロペンチ
ル、シクロヘキシル及び同効物)を意味し、「ア
リル基」とはフエニル基もしくはC1〜C6アルキ
ル基、ハロゲン、ニトロ又はC1〜C6アルコキシ
からなる群から選ばれた1もしくはそれ以上の基
によつて任意に置換されたフエニル基を意味す
る。 Here, R 1 is hydrogen, a lower alkyl group, or R 4 CO, R 2 and R 3 are each independently hydrogen, a lower alkyl group, and an alkoxy group, and R 4 is hydrogen,
It is a lower alkyl group, a cycloalkyl group, or an allyl group. "Lower alkyl group" as used herein refers to straight chain and branched C1 - C6 alkyl groups,
"Alkoxy group" refers to straight chain and branched C1 - C6 alkoxy groups. "Cycloalkyl" refers to a cycloalkyl group having 3 to 6 ring carbon atoms (e.g.
cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and the like), and "allyl" refers to phenyl or C1 - C6 alkyl, halogen, nitro or C1 - C6 alkoxy; means a phenyl group optionally substituted with one or more groups.
一般式のうち、或る種の化合物は既知の化合
物であつて、住血吸虫に対して駆虫活性を示す。 Certain compounds of the general formula are known compounds and exhibit anthelmintic activity against schistosomes.
ここに記載した一般式の化合物は先行技術と
して知られている種々の方法によつて製造されて
いる。 Compounds of the general formula described herein have been prepared by various methods known in the prior art.
米国特許第3993760号(1976)に記載された方
法では、一般式の化合物は1―(N―アシルア
ミノメチル)―2―ハロメチルカルボキシ―1,
2,3,4―テトラヒドロイソキノリンの環化に
よつて製造される。 In the method described in U.S. Pat. No. 3,993,760 (1976), compounds of the general formula 1-(N-acylaminomethyl)-2-halomethylcarboxy-1,
Produced by cyclization of 2,3,4-tetrahydroisoquinoline.
類似の又は他のプロセスはDOS2457971(1976)
及び2504250(1976)及びExperientia33,1036
(1977)に記載されている。 Similar or other processes DOS2457971 (1976)
and 2504250 (1976) and Experientia 33 , 1036
(1977).
上記文献に記載されている先行技術は或る種の
固有の欠点を有する。例えば、米国特許3993,
760(1976)で明らかにされたプロセスは、出発物
質である1―アミノメチル1,2,3,4―テト
ラヒドロイソキノリンを1―シアノ―2―アシル
―1,2―デヒドロイソキノリンから製造するた
め高温(〜100℃)下で高圧の触媒的な水素化を
必要とする。DOS2457971及び2504250(1976)及
びExperientia33 1036(1977)に記載されている
他のプロセスは工業的適用に対して経済的な魅力
はない。 The prior art described in the above documents has certain inherent drawbacks. For example, U.S. Patent No. 3993,
760 (1976), the process uses high temperatures to produce the starting material 1-aminomethyl 1,2,3,4-tetrahydroisoquinoline from 1-cyano-2-acyl-1,2-dehydroisoquinoline. Requires high pressure catalytic hydrogenation under (~100°C). Other processes described in DOS 2457971 and 2504250 (1976) and Experientia 33 1036 (1977) are not economically attractive for industrial applications.
それ故に、これらの先行技術の有するこれらの
欠点を克服することが本発明の目的である。 It is therefore an object of the present invention to overcome these drawbacks of the prior art.
本発明の他の目的は大スケールで一般式の化
合物を製造するための簡単で且つ経済的なプロセ
スを提供するにある。 Another object of the invention is to provide a simple and economical process for preparing compounds of the general formula on a large scale.
今、我々は一般式の化合物の新規な製造方法
を見出した。その方法とは、次の一般式または
で表わされる化合物をそれぞれ無関係に分子内
環化反応を行うことである。 We have now found a new method for producing compounds of the general formula. The method is to perform an intramolecular cyclization reaction on each compound represented by the following general formula or.
ここで、R1,R2,R3及びR4は先に定義したと
おりであり、R5はメチル、又はエチル或は両方
のR5が一緒でメチレン基である。 Here, R 1 , R 2 , R 3 and R 4 are as defined above, and R 5 is methyl, or ethyl, or both R 5 together are a methylene group.
この発明の新規性はイソキノリン環及びピペラ
ジン環を同時に、若しくは段階的に分子内環化反
応によつて形成するのである。 The novelty of this invention is that the isoquinoline ring and the piperazine ring are formed simultaneously or stepwise by an intramolecular cyclization reaction.
本発明に従つて、R1がアシル置換基である一
般式の化合物は直接一般式の化合物に転化さ
れるか又は所望ならば或る反応条件下では単離で
きる一般式又はの中間体を経て転化すること
ができる。 According to the invention, compounds of the general formula in which R 1 is an acyl substituent are converted directly into compounds of the general formula or via intermediates of the general formula which can be isolated under certain reaction conditions if desired. can be transformed.
一般式の化合物はまた一般式の化合物へ直
接または一般式の中間体を経て転化される。 Compounds of the general formula can also be converted directly or via intermediates of the general formula to compounds of the general formula.
本発明のプロセスは酸の媒体中で都合よく行な
われる。過剰の酸は溶媒として使用されるか、或
は反応は有機溶剤中で行なわれる。 The process of the invention is conveniently carried out in an acidic medium. Excess acid is used as a solvent or the reaction is carried out in an organic solvent.
本発明のプロセスで使用される適当な酸には硫
酸、塩酸、りん酸、ポリりん酸(PPA)、ぎ酸、
酢酸、トリクロロ酢酸、トリフロロ酢酸、メタン
スルホン酸、パラトルエンスルホン酸、及び三弗
化硼素エーテル錯化合物が含まれる。 Suitable acids for use in the process of the invention include sulfuric acid, hydrochloric acid, phosphoric acid, polyphosphoric acid (PPA), formic acid,
Included are acetic acid, trichloroacetic acid, trifluoroacetic acid, methanesulfonic acid, paratoluenesulfonic acid, and boron trifluoride ether complexes.
適当な有機溶剤にはジクロロメタン、クロロフ
オルム、四塩化炭素、1,2―ジクロロエタン、
メタノール、エタノール、イソプロパノール、
1,4―ジオキサン、テトラヒドロフラン
(THF)、ジエチルエーテル、エチレングリコー
ル、ジメチルエーテル及びアセトニトリルが含ま
れる。 Suitable organic solvents include dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane,
methanol, ethanol, isopropanol,
Includes 1,4-dioxane, tetrahydrofuran (THF), diethyl ether, ethylene glycol, dimethyl ether and acetonitrile.
一般式又はの化合物の一般式の化合物へ
の1段階での転化は溶剤なしで強酸の媒体中20℃
から40℃の温度で行なうことが望ましい。濃硫酸
またはメタンスルホン酸が適当である。反応は通
常約2時間ないし8時間で完結する。 The one-step conversion of a compound of the general formula or to a compound of the general formula is carried out at 20°C in a strong acid medium without a solvent.
It is desirable to carry out the test at a temperature between 40℃ and 40℃. Concentrated sulfuric acid or methanesulfonic acid are suitable. The reaction is usually completed in about 2 to 8 hours.
一般式又はの化合物の環化反応を触媒量の
酸の存在下、上に述べた有機溶剤中で行つたとき
には一般式の化合物がすぐれた収量で単離され
る。 When the cyclization reaction of compounds of general formula or is carried out in the organic solvents mentioned above in the presence of a catalytic amount of acid, compounds of general formula are isolated in excellent yields.
一般式の化合物はRがアシル置換基の一般式
の化合物を低温下好ましくは10℃ないし20℃で
約30分間強酸で処理し、その後アルカリ水溶液に
添加したときに単離される。 Compounds of the general formula are isolated when a compound of the general formula in which R is an acyl substituent is treated with a strong acid at low temperature, preferably from 10°C to 20°C, for about 30 minutes and then added to an aqueous alkaline solution.
一般式又はの化合物の一般式の化合物へ
の環化は一般式またはの化合物から一般式
の化合物の製造について前記したような強酸の媒
体中で行なわれる。通常この反応は溶剤なしで約
室温下で行なわれる。 The cyclization of compounds of general formula or to compounds of general formula is carried out in a strongly acidic medium as described above for the preparation of compounds of general formula from compounds of general formula or. This reaction is usually carried out without solvent at about room temperature.
この発明における分子内環化反応は文献〔Tet.
Let.No.44 4493(1972)及び同誌No.11 935(1977)〕
に同様な反応が記載されていることによつて理論
的に支持される。 The intramolecular cyclization reaction in this invention is described in the literature [Tet.
Let.No.44 4493 (1972) and the same magazine No.11 935 (1977)]
This is theoretically supported by the description of a similar reaction in .
R1がアシル置換基である一般式の化合物は
R1が水素である一般式の化合物をアシルクロ
ライド又は酸無水物でアシル化することによつて
製造される。 Compounds of the general formula where R 1 is an acyl substituent are
It is produced by acylating a compound of the general formula in which R 1 is hydrogen with an acyl chloride or an acid anhydride.
一般式の化合物である出発物質は単にN―
(2―フエニル)エチルモノクロロアセトアミド
〔J ACS55 2555(1933)〕をN―置換又は不置
換のアミノアセトアルデヒドジアルキルアセター
ルと反応させることにより製造される。 The starting material, which is a compound of the general formula, is simply N-
It is produced by reacting (2-phenyl)ethyl monochloroacetamide [J ACS 55 2555 (1933)] with an N-substituted or unsubstituted aminoacetaldehyde dialkyl acetal.
一般式の化合物はN―(2,2―ジアルコキ
シ)エチルフエネチルアミン(フエネチルアミン
とクロロ又はブロモアセトアルデヒドジアルキル
アセタールから製造)をN―アシルグリシンで処
理することによつて製造する。 Compounds of the general formula are prepared by treating N-(2,2-dialkoxy)ethylphenethylamine (made from phenethylamine and chloro or bromoacetaldehyde dialkyl acetal) with N-acylglycine.
更に以下の実施例は本発明を説明するが、これ
らはこの発明を限定するものではない。 The following examples further illustrate the invention without limiting it.
実施例 1
(±)―4―オキソ―1,2,3,6,7,
11b―ヘキサヒドロ―4H―ピラジノ〔2,1―
a〕イソキノリン(:R1=R2=R3=H)
N―(2―フエニル)エチル―α―N―(2,
2―ジメトキシ)エチルグリシンアミド(:
R1=R2=R3=H,R5=CH3)22.6gを冷却しな
がら濃硫酸40ml中に添加、この混合物を室温で3
時間攪拌反応させる。反応完結後、得られた混合
物を氷水中に注ぎ、その後、冷却しながら約20%
苛性ソーダ水溶液で中和する。中和した溶液をジ
エチルエーテルで抽出し、このエーテル抽出物を
濃縮すると、m.p118〜120℃の生成物12.3g(61
%)を得た。Example 1 (±)-4-oxo-1,2,3,6,7,
11b-hexahydro-4H-pyrazino [2,1-
a] Isoquinoline (:R 1 = R 2 = R 3 = H) N-(2-phenyl)ethyl-α-N-(2,
2-dimethoxy)ethylglycinamide (:
22.6 g of R 1 = R 2 = R 3 = H, R 5 = CH 3 ) was added to 40 ml of concentrated sulfuric acid while cooling, and the mixture was stirred at room temperature for 30 minutes.
Stir and react for some time. After the reaction is completed, the resulting mixture is poured into ice water and then reduced to about 20% while cooling.
Neutralize with aqueous caustic soda solution. The neutralized solution was extracted with diethyl ether and the ether extract was concentrated to give 12.3 g (61
%) was obtained.
実施例 2
(±)―4―オキソ―1,2,3,6,7,
11b―ヘキサヒドロ―4H―ピラジノ〔2,1―
a〕イソキノリン(:R1=R2=R3=H)
濃硫酸10mlとアセトニトリル5mlとの混合物に
N―(2―フエニル)エチル―α―N―(2,2
―ジメトキシ)エチルグリシンアミド(:R1
=R2=R3=H,R5=CH3)2.7gを添加、得られ
た混合物を室温で5時間撹拌する。反応混合物は
実施例1と同じような操作を行うと生成物1.8g
(89%)を得た。Example 2 (±)-4-oxo-1,2,3,6,7,
11b-hexahydro-4H-pyrazino [2,1-
a] Isoquinoline (: R 1 = R 2 = R 3 = H) N-(2-phenyl)ethyl-α-N-(2,2
-dimethoxy)ethylglycinamide (:R 1
=R 2 =R 3 =H, R 5 =CH 3 ) 2.7 g are added and the resulting mixture is stirred at room temperature for 5 hours. When the reaction mixture was operated in the same manner as in Example 1, 1.8 g of product was obtained.
(89%).
アセトニトリルの代りに溶剤としてジエチルエ
ーテルを使用したとき、反応は同じ生成物を与え
る。 The reaction gives the same product when diethyl ether is used as the solvent instead of acetonitrile.
実施例 3
(±)―2―シクロヘキサンカルボニル―4―
オキソ―1,2,3,6,7,11b―ヘキサヒ
ドロ―4H―ピラジノ〔2,1―a〕イソキノ
リン(:R1:シクロヘキサンカーボニル、
R2=R3=H〕
N―(2―フエニル)エチル―α―〔N―
(2,2―ジメトキシ)エチル―N―シクロヘキ
サンカーボニル)グリシンアミド(:R1=シ
クロヘキサンカーボニル、R2=R3=H,R5=メ
チル)3.76g(0.01モル)をメタンスルホン酸20
mlに添加し、生じた混合物を室温で8時間撹拌す
る。反応混合物を真空下で濃縮しそれから残渣を
水で稀釈、10%苛性ソーダ水溶液で中和する。中
和した溶液をジクロロメタン抽出し、抽出物を濃
縮する。残渣を酢酸エチルで再結晶するとm.
p133〜134℃の生成物1.9g(61%)を得る。Example 3 (±)-2-cyclohexanecarbonyl-4-
Oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinoline (: R 1 : cyclohexane carbonyl,
R 2 = R 3 = H] N-(2-phenyl)ethyl-α-[N-
(2,2-dimethoxy)ethyl-N-cyclohexanecarbonyl)glycinamide (: R 1 = cyclohexane carbonyl, R 2 = R 3 = H, R 5 = methyl) 3.76 g (0.01 mol) was mixed with methanesulfonic acid 20
ml and the resulting mixture is stirred at room temperature for 8 hours. The reaction mixture is concentrated under vacuum, then the residue is diluted with water and neutralized with 10% aqueous sodium hydroxide solution. The neutralized solution is extracted with dichloromethane and the extract is concentrated. When the residue is recrystallized from ethyl acetate, m.
1.9 g (61%) of product with p 133-134° C. are obtained.
実施例 4
(±)―2―ベンゾイル―4―オキソ―1,
2,3,6,7,11b―ヘキサヒドロ―4H―ピラ
ジノ〔2,1―a〕イソキノリン(:R1=ベ
ンゾイル、R2=R3=H)ジエチルエーテル5ml
中N―(2―フエニル)エチル―α―〔N―
(2,2―ジメトキシ)エチル―N―ベンゾイル〕
グリシンアミド3.7gの溶液を濃硫酸10ml中にゆ
つくりと添加する。混合物を室温で7時間撹拌す
る。反応が完結後、生じた混合物を氷水の中に注
ぎアルカリ水溶液で中和する。生じた溶液をジエ
チルエーテルで抽出し、その後、エーテル抽出物
を濃縮する。残渣を酢酸エチルで再結晶すると
m.p162〜163℃の生成物1.8g(68%)を得る。Example 4 (±)-2-benzoyl-4-oxo-1,
2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinoline (: R 1 = benzoyl, R 2 = R 3 = H) diethyl ether 5 ml
N-(2-phenyl)ethyl-α-[N-
(2,2-dimethoxy)ethyl-N-benzoyl]
A solution of 3.7 g of glycinamide is slowly added to 10 ml of concentrated sulfuric acid. The mixture is stirred at room temperature for 7 hours. After the reaction is complete, the resulting mixture is poured into ice water and neutralized with aqueous alkaline solution. The resulting solution is extracted with diethyl ether and then the ether extract is concentrated. When the residue is recrystallized from ethyl acetate,
1.8 g (68%) of product with m.p 162-163°C are obtained.
実施例 5
1―(2―フエニル)エチル―4―アセチル―
2―ヒドロキシピペラジン―6―オン(:
R1=アセチル、R2=R3=H)
濃硫酸5mlにN―(2―フエニル)エチル―α
―〔N―(2,2―ジメトキシ)エチル―N―ア
セチル〕グリシンアミド(:R1=アセチル、
R2=R3=H、R5=メチル)3.08gを添加する。
混合物を室温で30分間撹拌する。反応混合物を冷
却しながら約10%の苛性ソーダ水溶液にゆつくり
と添加する。生じた混合物をジクロロメタンで抽
出し抽出物を濃縮する。残渣を酢酸エチル・ヘキ
サン混合溶媒で再結晶すると生成物2.4g(92%)
を得る。この生成物は融点128〜129℃、nmr
(CDCl3)〓:2.05(S,3COCH3)、2.65〜4.80(m,
10,CH2,CH)、7.20(S,5,フエニル環プロ
トン)、IR(KBr)cm-1;3350(S,OH)、2930
(m,CH)、1650(S,CO)、1420〜1480(S)、
1170(S)である。Example 5 1-(2-phenyl)ethyl-4-acetyl-
2-Hydroxypiperazin-6-one (:
R 1 = acetyl, R 2 = R 3 = H) N-(2-phenyl)ethyl-α in 5 ml of concentrated sulfuric acid
-[N-(2,2-dimethoxy)ethyl-N-acetyl]glycinamide (: R 1 = acetyl,
3.08 g of R 2 = R 3 = H, R 5 = methyl) are added.
Stir the mixture for 30 minutes at room temperature. The reaction mixture is slowly added to an approximately 10% aqueous solution of caustic soda while cooling. The resulting mixture is extracted with dichloromethane and the extract is concentrated. When the residue was recrystallized from a mixed solvent of ethyl acetate and hexane, 2.4 g (92%) of the product was obtained.
get. This product has a melting point of 128-129℃, nmr
(CDCl 3 ) = 2.05 (S, 3COCH 3 ), 2.65-4.80 (m,
10, CH 2 , CH), 7.20 (S, 5, phenyl ring proton), IR (KBr) cm -1 ; 3350 (S, OH), 2930
(m, CH), 1650 (S, CO), 1420-1480 (S),
1170(S).
実施例 6
1―(2―フエニル)エチル―4―シクロヘキ
サンカルボニル―2,3―デヒドロピペラジン
―6―オン(V:R4=シクロヘキシル、R2=
R3=H)
ジクロロメタン10ml中にN―(2―フエニル)
エチル―N―(2,2―ジエトキシ)エチル―α
―N―シクロヘキサンカルボニルグリシンアミド
(:R4=シクロヘキシル、R2=R3=H,R5=
エチル)4.0gの溶液にメタンスルホン酸1mlを
添加し、この混合物を室温で3時間撹拌する。反
応混合物をアルカリ水溶液で洗滌後、有機層を濃
縮する。残渣を酢酸エチル―ヘキサン混合溶媒で
再結晶するとm.p128〜130℃の製品2.8g(90%)
を得る。この生成物はnmr(CDCl3)〓,0.85〜2.0
(m,10,シクロヘキサン環プロトン)、2.90(t,
2,CH2)、3.70(t,2,CH2)、4.20(S,2,
CH2)、5.30(d,l、ビニルプロトン)、600(d,
l、ビニルプロトン)、7,10(S,t,フエニル
環プロトン)、IR(KBr)cm-1:2930(m,CH)、
1660(S,CO)、1450,1400(m)、1300(m)、
1000(m)、700(w)。Example 6 1-(2-phenyl)ethyl-4-cyclohexanecarbonyl-2,3-dehydropiperazin-6-one (V: R 4 = cyclohexyl, R 2 =
R 3 = H) N-(2-phenyl) in 10 ml of dichloromethane
Ethyl-N-(2,2-diethoxy)ethyl-α
-N-cyclohexanecarbonylglycinamide (: R 4 = cyclohexyl, R 2 = R 3 = H, R 5 =
1 ml of methanesulfonic acid is added to a solution of 4.0 g (ethyl) and the mixture is stirred at room temperature for 3 hours. After washing the reaction mixture with an aqueous alkali solution, the organic layer is concentrated. When the residue was recrystallized from a mixed solvent of ethyl acetate and hexane, 2.8 g (90%) of product with m.p 128-130°C was obtained.
get. This product has nmr( CDCl3 )〓,0.85~2.0
(m, 10, cyclohexane ring proton), 2.90 (t,
2, CH 2 ), 3.70 (t, 2, CH 2 ), 4.20 (S, 2,
CH 2 ), 5.30 (d, l, vinyl proton), 600 (d,
l, vinyl proton), 7,10 (S, t, phenyl ring proton), IR (KBr) cm -1 :2930 (m, CH),
1660 (S, CO), 1450, 1400 (m), 1300 (m),
1000 (m), 700 (w).
実施例 7
(±)―2―シクロヘキサンカーボニル―4―
オキソ―1,2,3,6,7,11b―ヘキサヒ
ドロ―4H―ピラジノ〔2,1―a〕イソキノ
リン(:R1=シクロヘキサンカーボニル、
R2=R3=H)
1―(2―フエニル)エチル―4―シクロヘキ
サンカーボニル―2―ヒドロキシピペラジン―6
―オン(:R2=R3=H,R1=シクロヘキサン
カーボニル)3.3gを濃硫酸5ml中にゆつくりと
添加する。混合物を室温で3時間撹拌する。反応
混合物を氷水中に注ぎアルカリ水溶液で中和す
る。生じた混合物をジクロロメタンで抽出後、抽
出物を濃縮する。残渣を酢酸エチルで再結晶する
とm.p132〜134℃の生成物3.0g(95%)を得る。Example 7 (±)-2-cyclohexane carbonyl-4-
Oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinoline (: R 1 = cyclohexane carbonyl,
R 2 = R 3 = H) 1-(2-phenyl)ethyl-4-cyclohexanecarbonyl-2-hydroxypiperazine-6
3.3 g of -on (: R 2 = R 3 = H, R 1 = cyclohexane carbonyl) are slowly added to 5 ml of concentrated sulfuric acid. The mixture is stirred at room temperature for 3 hours. The reaction mixture is poured into ice water and neutralized with aqueous alkaline solution. After extracting the resulting mixture with dichloromethane, the extract is concentrated. Recrystallization of the residue from ethyl acetate yields 3.0 g (95%) of product with m.p 132-134°C.
実施例 8
(±)―2―(アセチル―4―オキソ―1,
2,3,6,7,11b―ヘキサヒドロ―4H―ピ
ラジノ〔2,1―a〕イソキノリン(:R1
=アセチル、R2=R3=H)
N―(2―フエニル)エチル―N―(2,2―
ジエトキシ)エチル―α―N―アセチルグリシン
アミド(:R2=R3=H,R4=メチル)3.4gを
1,2―ジクロロエタン10mlにとかした溶液にメ
タンスルホン酸3mlを添加し、生じた混合物を8
時間環流する。反応が完結後、生成物をアルカリ
水溶液で洗滌、その後有機層を濃縮する。残渣を
酢酸エチルで再結晶すると生成物m.p.144〜145℃
2.1g(86%)を得る。Example 8 (±)-2-(acetyl-4-oxo-1,
2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinoline (:R 1
= Acetyl, R 2 = R 3 = H) N-(2-phenyl)ethyl-N-(2,2-
To a solution of 3.4 g of diethoxy)ethyl-α-N-acetylglycinamide (: R 2 = R 3 = H, R 4 = methyl) dissolved in 10 ml of 1,2-dichloroethane, 3 ml of methanesulfonic acid was added. 8 of the mixture
Time circulates. After the reaction is completed, the product is washed with aqueous alkaline solution, and then the organic layer is concentrated. When the residue is recrystallized from ethyl acetate, the product mp144-145℃
Obtain 2.1g (86%).
実施例 9
1―(2―フエニル)エチル―4―シクロヘキ
サンカーボニル―2,3―デヒドロピラジン―
6―オン(:R2=R3=H,R4=シクロヘキ
シル)
N―(2―フエニル)エチル―α―〔N―
(2,2―ジメトキシ)エチル―N―シクロヘキ
サンカーボニル〕グリシンアミド(:R1=シ
クロヘキサンカーボニル、R2=R3=H、R5=メ
チル)3.8gを20%塩酸5mlに添加し得られた混
合物を室温で3時間撹拌する。反応を完結後生じ
た固体を過によつて捕集すると、m.p.129゜〜
131℃の生成物2.9g(93%)を得る。Example 9 1-(2-phenyl)ethyl-4-cyclohexanecarbonyl-2,3-dehydropyrazine-
6-one (:R 2 = R 3 = H, R 4 = cyclohexyl) N-(2-phenyl)ethyl-α-[N-
Obtained by adding 3.8 g of (2,2-dimethoxy)ethyl-N-cyclohexanecarbonyl]glycinamide (: R 1 = cyclohexane carbonyl, R 2 = R 3 = H, R 5 = methyl) to 5 ml of 20% hydrochloric acid. The mixture is stirred at room temperature for 3 hours. When the solid produced after the reaction is completed is collected by filtration, mp129°~
2.9 g (93%) of product are obtained at 131°C.
実施例 10
(±)―4―オキソ―9,10―ジメトキシ―
1,2,3,6,7,11b―ヘキサヒドロ―4H
―ピラジノ〔2,1―a〕イソキノリン(:
R1=H,R2=R3=OCH3)
N―〔2―(3,4―ジメトキシフエニル)エ
チル〕―α―N―(2,2―ジメトキシ)エチル
グリシンアミド(:R1=H,R2=R3=OCH3,
R5=CH3)2.16gに0℃で濃硫酸2mlを添加、混
合物を1.5時間室温で撹拌する。生じた混合物を
氷水中に注ぎアルカリ水溶液でPH=8程度に中和
する。中和した溶液をジクロロメタンで抽出し、
抽出物を濃縮する。残渣を酢酸エチルで再結晶す
るとm.p.136〜137℃の生成物1.5g(96%)を得
る。この生成物はnmr(CDCl3)〓:2.0(S,l,
NH)、2.30〜3.10(m,4,CH2)3.30〜4.00(m,
3,CH2及びCH)、3.8(S,6,OCH3)、4.40〜
5.00(m,2,CH2)、6.5(S,2,フエニル環プ
ロトン)である。Example 10 (±)-4-oxo-9,10-dimethoxy-
1,2,3,6,7,11b-hexahydro-4H
-Pyrazino[2,1-a]isoquinoline (:
R 1 = H, R 2 = R 3 = OCH 3 ) N-[2-(3,4-dimethoxyphenyl)ethyl]-α-N-(2,2-dimethoxy)ethyl glycinamide (:R 1 = H, R 2 = R 3 = OCH 3 ,
2.16 g of R 5 =CH 3 ) are added with 2 ml of concentrated sulfuric acid at 0° C. and the mixture is stirred for 1.5 hours at room temperature. The resulting mixture is poured into ice water and neutralized to approximately PH=8 with an aqueous alkaline solution. Extract the neutralized solution with dichloromethane,
Concentrate the extract. Recrystallization of the residue from ethyl acetate yields 1.5 g (96%) of product with mp 136-137°C. This product is nmr (CDCl 3 ) = 2.0 (S, l,
NH), 2.30-3.10 (m, 4, CH2 ) 3.30-4.00 (m,
3, CH 2 and CH), 3.8 (S, 6, OCH 3 ), 4.40 ~
5.00 (m, 2, CH 2 ), 6.5 (S, 2, phenyl ring proton).
実施例 11
(±)―2―(p―クロロベンゾイル)―4―
オキソ―9.10―ジメトキシ―1,2,3,6,
7,11b―ヘキサヒドロ―4H―ピラジノ〔2,
1―a〕イソキノリン(:R1=p―クロロ
ベンゾイル R2=R3=OCH3)
(±)―4―オキソ―9,10―ジメトキシ―
1,2,3,6,7,11b―ヘキサヒドロ―4H―
ピラジノ〔2,1―a〕イソキノリン(:R1
=H,R2=R3=OCH3)2.62gをジクロロメタン
10mlに溶かした溶液にトリエチルアミン2mlを添
加後、p―クロロベンゾイル塩化物1.9gを0〜
5℃でゆつくりと加える。生じた混合物を10℃で
1.5時間撹拌する。この反応混合物に水を加えた
有機層を分離させ、有機抽出物を濃縮し、残渣を
酢酸エチル―エーテル混合液でこまかくすり砕く
とm.p.139〜140℃の生成物4.0g(100%)を得
る。Example 11 (±)-2-(p-chlorobenzoyl)-4-
Oxo-9.10-dimethoxy-1,2,3,6,
7,11b-hexahydro-4H-pyrazino [2,
1-a] Isoquinoline (: R 1 = p-chlorobenzoyl R 2 = R 3 = OCH 3 ) (±)-4-oxo-9,10-dimethoxy-
1,2,3,6,7,11b-hexahydro-4H-
Pyrazino[2,1-a]isoquinoline (:R 1
= H, R 2 = R 3 = OCH 3 ) 2.62 g in dichloromethane
After adding 2 ml of triethylamine to a solution dissolved in 10 ml, 1.9 g of p-chlorobenzoyl chloride was added to
Add slowly at 5℃. The resulting mixture was heated at 10°C.
Stir for 1.5 hours. Water was added to the reaction mixture, the organic layer was separated, the organic extract was concentrated, and the residue was triturated with ethyl acetate-ether mixture to obtain 4.0 g (100%) of the product, mp 139-140°C.
実施例 12
N―〔2―(3,4―ジメトキシフエニル)エ
チル〕―α―N―(2,2―ジメトキシ)エチ
ルグリシンアミド(:R1=H,R2=R3=
OCH3)
N―(3,4―ジメトキシフエニル)エチルモ
ノクロロアセタミド12.86gとアミノアセトアル
デヒドジメチルアセタール11.6gとをトルエン10
mlに添加し混合物を40分間還流する。反応混合物
を冷却後、生じた固体を過してしまう。過液
を水で洗滌後トルエン溶液を濃縮すると粘稠な油
状物(11.19g、99.3%)を得、その塩酸塩の融
点は98〜99℃である。Example 12 N-[2-(3,4-dimethoxyphenyl)ethyl]-α-N-(2,2-dimethoxy)ethylglycinamide (: R 1 = H, R 2 = R 3 =
OCH 3 ) 12.86 g of N-(3,4-dimethoxyphenyl)ethyl monochloroacetamide and 11.6 g of aminoacetaldehyde dimethyl acetal were mixed with 10 g of toluene.
ml and the mixture is refluxed for 40 minutes. After cooling the reaction mixture, the solid formed is filtered off. After washing the filtrate with water, the toluene solution was concentrated to obtain a viscous oil (11.19 g, 99.3%), the hydrochloride of which had a melting point of 98-99°C.
Claims (1)
溶剤を含有しない酸の媒体の中で一般式を有す
る化合物 または、一般式を有する化合物 の分子内環化反応を行なわせることからなる下記
の一般式 で示される(±)―4―オキソ―1,2,3,
6,7,11b―ヘキサヒドロ―4H―ピラジノ
〔2,1―a〕イソキノリン誘導体の製造方法。 ただし、一般式,及びにおいて、R1は
水素、低級アルキル基またはR4COを表わし、R2
及びR3はそれぞれ別個に水素、低級アルキル基
またはアルコキシ基を表わし、R4は水素、低級
アルキル基、シクロアルキル基またはアリル基を
表わし、R5はメチル基またはエチル基或は両方
のR5が一緒でメチレン基を表わす、 2 前記の酸が硫酸、塩酸、りん酸、ポリりん酸
(PPA)、ぎ酸、酢酸、トリクロロ酢酸、トリフ
ロロ酢酸、メタンスルホン酸、パラトルエンスル
ホン酸および三弗化硼素エーテル錯化合物よりな
る群から選ばれた酸である特許請求の範囲第1項
記載の化合物の製造方法。 3 有機溶剤が存在するとき該有機溶剤がジクロ
ロメタン、クロロホルム、四塩化炭素、1,2―
ジクロロエタン、メタノール、エタノール、イソ
プロパノール、1,4―ジオキサン、テトラヒド
ロフラン(THF)、ジエチルエーテル、エチレン
グリコール、ジメチルエーテル、およびアセトニ
トリルよりなる群から選ばれた有機溶剤である特
許請求の範囲第1項記載の化合物の製造方法。 4 前記一般式においてR1がR4COである化合
物の環化反応を酸および有機溶剤の存在下で下記
一般式を有する中間体化合物 を経由し2段反応で行う特許請求の範囲第1項記
載の化合物の製造方法。 ただし、R1はR4COを表わし、R2及びR3は夫々
別個に水素、低級アルキル基、又はアルコキシ基
を表わし、R4は水素、低級アルキル基、シクロ
アルキル基又はアリル基を表わす。 5 前記一般式又はを有する化合物の環化反
応を、酸及び有機溶剤の存在下で下記一般式を
有する中間化合物 を経由し2段反応で行う特許請求の範囲第1項記
載の化合物の製造方法。 ただし、R2およびR3は夫々別個に水素、低級
アルキル基、又はアルコキシ基を表わし、R4は
水素、低級アルキル基、シクロアルキル基又はア
リル基を表わす。 6 転化を20℃ないし40℃の温度で行う特許請求
の範囲第1項記載の化合物Iの製造方法。 7 酸処理を10℃ないし20℃の温度で行う特許請
求の範囲第4項記載の製造方法。[Scope of Claims] 1. A compound having the general formula in an acid medium containing an organic solvent or an acid medium not containing an organic solvent or a compound having the general formula The following general formula consists of performing an intramolecular cyclization reaction of (±)-4-oxo-1,2,3,
A method for producing a 6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinoline derivative. However, in the general formula and, R 1 represents hydrogen, a lower alkyl group, or R 4 CO, and R 2
and R 3 each independently represent hydrogen, a lower alkyl group, or an alkoxy group, R 4 represents hydrogen, a lower alkyl group, a cycloalkyl group, or an allyl group, and R 5 represents a methyl group, an ethyl group, or both R 5 together represent a methylene group, 2. The acids mentioned above are sulfuric acid, hydrochloric acid, phosphoric acid, polyphosphoric acid (PPA), formic acid, acetic acid, trichloroacetic acid, trifluoroacetic acid, methanesulfonic acid, para-toluenesulfonic acid and trifluoride. A method for producing the compound according to claim 1, which is an acid selected from the group consisting of boron ether complex compounds. 3 When an organic solvent is present, the organic solvent is dichloromethane, chloroform, carbon tetrachloride, 1,2-
The compound according to claim 1, which is an organic solvent selected from the group consisting of dichloroethane, methanol, ethanol, isopropanol, 1,4-dioxane, tetrahydrofuran (THF), diethyl ether, ethylene glycol, dimethyl ether, and acetonitrile. manufacturing method. 4 The cyclization reaction of a compound in which R 1 is R 4 CO in the above general formula is carried out in the presence of an acid and an organic solvent to form an intermediate compound having the following general formula. A method for producing the compound according to claim 1, which is carried out in a two-stage reaction via. However, R 1 represents R 4 CO, R 2 and R 3 each independently represent hydrogen, a lower alkyl group, or an alkoxy group, and R 4 represents hydrogen, a lower alkyl group, a cycloalkyl group, or an allyl group. 5 The cyclization reaction of the compound having the above general formula or the intermediate compound having the following general formula in the presence of an acid and an organic solvent A method for producing the compound according to claim 1, which is carried out in a two-stage reaction via. However, R 2 and R 3 each independently represent hydrogen, a lower alkyl group, or an alkoxy group, and R 4 represents hydrogen, a lower alkyl group, a cycloalkyl group, or an allyl group. 6. A process for producing compound I according to claim 1, wherein the conversion is carried out at a temperature of 20°C to 40°C. 7. The manufacturing method according to claim 4, wherein the acid treatment is carried out at a temperature of 10°C to 20°C.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1982-3036 | 1982-07-08 | ||
| KR8203036A KR840000250B1 (en) | 1982-07-08 | 1982-07-08 | Method for preparing 4-oxo-1,3,4,6,7,11b-hexahydro-4H-pyrazino [2,1-a] isoquinoline derivative |
| KR1983-2418 | 1983-05-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59139383A JPS59139383A (en) | 1984-08-10 |
| JPH0119393B2 true JPH0119393B2 (en) | 1989-04-11 |
Family
ID=19225075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58122444A Granted JPS59139383A (en) | 1982-07-08 | 1983-07-07 | Manufacture of (+-)-4-oxo-1,2,3,6,7,11b-hexahydro-4h- pyrazino(2,1-a)isoquinoline derivatives |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS59139383A (en) |
| KR (1) | KR840000250B1 (en) |
-
1982
- 1982-07-08 KR KR8203036A patent/KR840000250B1/en not_active Expired
-
1983
- 1983-07-07 JP JP58122444A patent/JPS59139383A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| KR840000547A (en) | 1984-02-25 |
| KR840000250B1 (en) | 1984-03-08 |
| JPS59139383A (en) | 1984-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6061158B2 (en) | Synthesis intermediate of 6- (7-((1-aminocyclopropyl) methoxy) -6-methoxyquinolin-4-yloxy) -N-methyl-1-naphthamide, or a pharmaceutically acceptable salt thereof, and its use | |
| FR2676443A1 (en) | NOVEL PERHYDROISOINDOLE DERIVATIVES AND THEIR PREPARATION. | |
| US4497952A (en) | Process for the production of (±)-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinoline derivatives | |
| JPH0479349B2 (en) | ||
| US5672706A (en) | Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane | |
| EP1611084A1 (en) | Process for the manufacture of n-alkoxalyl-alaninates | |
| JPH0119393B2 (en) | ||
| JP2002501531A (en) | Method for producing substituted keto-enamines | |
| US20040138232A1 (en) | Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity | |
| JP2001521498A (en) | Method for producing O- (3-amino-2-hydroxy-propyl) -hydroxymic acid halide | |
| US4963684A (en) | Process for preparing cotarnine | |
| US6426417B1 (en) | Processes and intermediates useful to make antifolates | |
| JP2002540101A (en) | Synthesis of 3-amino-3-aryl propionate | |
| US4709086A (en) | Process for the preparation of 4-benzyl aspartate | |
| KR100850558B1 (en) | Efficient preparation of atorvastatin | |
| KR850001227B1 (en) | Method for preparing 2-acyl-4-oxo-1, 3, 4, 6, 7, 11b-hexahydro-4H-pyrazino [2, 1-a] isoquinoline derivative | |
| JPH1129540A (en) | Method for producing ester derivative | |
| US7122674B2 (en) | Process for preparing high-purity hydroxyindolylglyoxylamides | |
| KR100208297B1 (en) | Novel process for preparing cephem derivatives | |
| KR100192123B1 (en) | New process for preparing bicyclic amines | |
| JP4351316B2 (en) | Benzoxazole derivatives and process for producing the same | |
| KR20250117368A (en) | Method for preparing (Z)-3-(2-(5-bromo-1H-indol-3-yl)-2-cyanovinyl)-4-methoxybenzonitrile | |
| CN115650950A (en) | Rui Lu Geli intermediate and preparation method thereof, and amide condensation method | |
| KR0151818B1 (en) | Process for the preparation of pyridyl imidazole derivatives | |
| RU2108326C1 (en) | Method of synthesis of 2-carboxy-3-[2-(dimethylamino)-ethyl]- -n-methyl-1h-indole-5-methane sulfoneamide |